Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SEPSECS-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IL6ST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NCOR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AZI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP350 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506546 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRSN2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDLIM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GADD45A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TET2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on